⚕ GalenOps CRO console
← 702 (USA)

702-1082

withdrawn
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 702 (USA) (Dr. Nolan) · consented 2013-07-26
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-09-09 (study day 46.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild NEUTROPHIL COUNT INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed 2026-08-18

Mild NEUTROPHIL COUNT INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed 2026-08-18

Mild RECTAL HAEMORRHAGE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-02 (study day 39.0); relationship: NONE

mild assessed 2026-08-18

Mild RECTAL HAEMORRHAGE — outcome: RECOVERED/RESOLVED; onset 2013-09-02 (study day 39.0); relationship: NONE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 79.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild URINE ANALYSIS ABNORMAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed 2026-08-18

Mild URINE ANALYSIS ABNORMAL — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed 2026-08-18

Mild WHITE BLOOD CELL COUNT INCREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

mild assessed 2026-08-18

Mild WHITE BLOOD CELL COUNT INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-07-07 (study day -19.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.